Remedy Meds Review 2026: Real Cost, Flat Pricing and Safety

Price checked 20 days ago

Our score

6.9/10

All-in from

$189/mo (microdose)

Medication type

Compounded (not FDA-approved)

Billing

Month to month, flat by dose

Remedy Meds at a glance

Remedy Meds charges one flat price per medication: $299 a month for compounded semaglutide, $399 for compounded tirzepatide, and $189 for a lower-dose microdose protocol. There is no membership fee and no prepay commitment, and the price includes unlimited clinician visits, supplies and shipping. Checked September 30, 2026.

The pricing model is the selling point

Most compounded programmes charge more as your dose rises, or advertise a low rate that only applies if you prepay six or twelve months. Remedy does neither. The price is the same on your first dose and your highest, billed monthly, and you can stop at any time. Across the brands we track, prices quoted by independent reviewers in June, July, August and September 2026 agreed on the same figures, which is unusual in this category and counts in Remedy’s favour.

But it is the most expensive compounded option we track

That consistency comes at a price. At $299 and $399 a month, Remedy sits at the top of the compounded market. For comparison, Ivim Health works out at about $150 a month all-in, Mochi from $139, and Henry Meds at $197 a month if you prepay for a year. If you are comfortable prepaying and your dose is stable, you can pay considerably less elsewhere. What you give up is the flexibility and the unlimited clinician access.

What is included

The monthly fee covers the medication, injection supplies, unlimited video visits and messaging with clinicians, dose adjustments and shipping, reported at around 48 hours. Remedy advertises a refund if you do not lose 10% of your body weight within four months, though as with any guarantee the conditions matter, so read them before relying on it. It is reported to operate in 49 states through U.S. 503A compounding pharmacies.

Is Remedy Meds legit and safe?

Remedy Meds is an established platform with a 4.7 out of 5 Trustpilot rating recorded during its intake flow in September 2026, and it discloses the compounded status of its medicines clearly. Two independent reviews refer to a 2025 FDA warning letter issued to Remedy Meds. We could not verify that against FDA enforcement records for this review, so treat it as unconfirmed and worth asking about. The standing caveat applies: compounded semaglutide and tirzepatide are not FDA-approved, and there is no brand-name route here if you want an approved medicine.

Who Remedy Meds is best for

It suits people who want certainty: one price that will not change as the dose goes up, no contract, and as much clinician contact as they need. It is a poor fit if you are optimising for cost, since several programmes deliver the same compounded medication for $100 to $200 less, or if you want FDA-approved medication, where LillyDirect and NovoCare now start at $149 a month.

Our verdict

Remedy Meds has the clearest pricing in the compounded category: one flat monthly figure, no membership, no prepay, and the same price at every dose. It is also the most expensive of its kind, so you are paying for certainty and unlimited clinician access rather than the lowest cost. This review is based on research of Remedy Meds’ public pages and independent sources on September 30, 2026, not hands-on testing, and follows our methodology. TirzaSema has no affiliate relationship with Remedy Meds.